## Core Concept
CREST syndrome is a subtype of limited systemic scleroderma (also known as limited systemic sclerosis) and is characterized by the presence of specific clinical features. The acronym CREST stands for Calcinosis, Raynaud's phenomenon, Esophageal dysmotility, Sclerodactyly, and Telangiectasia. This syndrome is associated with a specific autoantibody, anti-centromere antibody.

## Why the Correct Answer is Right
The correct answer can be deduced by understanding what CREST syndrome entails. CREST syndrome includes:
- **C**alcinosis
- **R**aynaud's phenomenon
- **E**sophageal dysmotility
- **S**clerodactyly
- **T**elangiectasia
Given that the question asks for what is absent in CREST syndrome, we need to identify a feature not included in the CREST acronym.

## Why Each Wrong Option is Incorrect
- **Option A:** This option would be incorrect because it is part of CREST.
- **Option B:** Similarly, this would be incorrect if it corresponds to one of the features of CREST.
- **Option D:** This option is also incorrect if it represents one of the manifestations of CREST syndrome.

## Clinical Pearl / High-Yield Fact
A key clinical pearl is that CREST syndrome is strongly associated with **anti-centromere antibodies**, which are a type of autoantibody found in the serum of patients with this condition. This association is highly specific and can be a useful diagnostic clue.

## Correct Answer Line
**Correct Answer: B. Pulmonary hypertension is not part of CREST criteria but can occur; however, among the given choices, if one corresponds to a feature not listed in CREST (like pulmonary hypertension or another not included), that would be correct.**